BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10227000)

  • 1. Hepatorenal syndrome and ascites--questions and answers.
    Bernardi M; Blendis L; Burroughs AK; Laffi G; Rodes J; Gentilini P
    Liver; 1999; 19(1 Suppl):15-74. PubMed ID: 10227000
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatorenal syndrome and ascites--an introduction.
    Gentilini P
    Liver; 1999; 19(1 Suppl):5-14. PubMed ID: 10226999
    [No Abstract]   [Full Text] [Related]  

  • 3. Ascites and Hepatorenal Syndrome.
    Adebayo D; Neong SF; Wong F
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.
    European Association for the Study of the Liver
    J Hepatol; 2010 Sep; 53(3):397-417. PubMed ID: 20633946
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cirrhosis and ascites.
    Ginès P; Cárdenas A; Arroyo V; Rodés J
    N Engl J Med; 2004 Apr; 350(16):1646-54. PubMed ID: 15084697
    [No Abstract]   [Full Text] [Related]  

  • 7. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N; Sanyal AJ
    Postgrad Med; 2001 Feb; 109(2):91-6, 101-3. PubMed ID: 11272697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of refractory ascites and hepatorenal syndrome.
    Chutaputti A
    J Gastroenterol Hepatol; 2002 Apr; 17(4):456-61. PubMed ID: 11982727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of ascites in liver cirrhosis].
    Gülberg V; Gerbes AL
    Internist (Berl); 1998 Mar; 39(3):254-62. PubMed ID: 9561446
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.
    Mookerjee RP; Jalan R
    Crit Care; 2008; 12(2):119. PubMed ID: 18394181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical recommendations for the treatment of ascites and its complications.
    Bataller R; Ginès P; Arroyo V
    Drugs; 1997 Oct; 54(4):571-80. PubMed ID: 9339961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A; Terra C; Guevara M; Ginès P
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract]   [Full Text] [Related]  

  • 15. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome.
    Blendis L; Wong F
    Clin Med (Lond); 2003; 3(2):154-9. PubMed ID: 12737373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN; Boyer TD
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.
    Arroyo V; Colmenero J
    J Hepatol; 2003; 38 Suppl 1():S69-89. PubMed ID: 12591187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.